These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33996815)
1. Gao M; Lin Y; Liu X; Zhao Z; Zhu Z; Zhang H; Ban Y; Bie Y; He X; Sun X; Zhang S Front Cell Dev Biol; 2021; 9():654407. PubMed ID: 33996815 [TBL] [Abstract][Full Text] [Related]
2. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas. Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624 [TBL] [Abstract][Full Text] [Related]
3. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data. Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Chan AK; Park CK; Fung KM; Hassell L Crit Rev Oncol Hematol; 2017 Dec; 120():1-9. PubMed ID: 29198322 [TBL] [Abstract][Full Text] [Related]
4. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion. Chen SC; Lo CM; Wang SH; Su EC BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275 [TBL] [Abstract][Full Text] [Related]
5. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
6. Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C. Eckel-Passow JE; Drucker KL; Kollmeyer TM; Kosel ML; Decker PA; Molinaro AM; Rice T; Praska CE; Clark L; Caron A; Abyzov A; Batzler A; Song JS; Pekmezci M; Hansen HM; McCoy LS; Bracci PM; Wiemels J; Wiencke JK; Francis S; Burns TC; Giannini C; Lachance DH; Wrensch M; Jenkins RB Neuro Oncol; 2020 Nov; 22(11):1602-1613. PubMed ID: 32386320 [TBL] [Abstract][Full Text] [Related]
7. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma. Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866 [TBL] [Abstract][Full Text] [Related]
8. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593 [TBL] [Abstract][Full Text] [Related]
9. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas. Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560 [TBL] [Abstract][Full Text] [Related]
11. Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma. Lv L; Zhang Y; Zhao Y; Wei Q; Zhao Y; Yi Q Front Cell Neurosci; 2021; 15():704344. PubMed ID: 34335194 [No Abstract] [Full Text] [Related]
12. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance. Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548 [TBL] [Abstract][Full Text] [Related]
13. Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification. Michiwaki Y; Hata N; Mizoguchi M; Hiwatashi A; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Togao O; Suzuki SO; Yoshimoto K; Iwaki T; Iihara K Clin Neurol Neurosurg; 2019 Dec; 187():105556. PubMed ID: 31639630 [TBL] [Abstract][Full Text] [Related]
15. TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline. Sun ZL; Chan AK; Chen LC; Tang C; Zhang ZY; Ding XJ; Wang Y; Sun CR; Ng HK; Yao Y; Zhou LF Int J Clin Exp Pathol; 2015; 8(9):11485-94. PubMed ID: 26617880 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of the isocitrate dehydrogenase gene and telomerase reverse transcriptase promoter mutations in gliomas in Chinese patients. Qu CX; Ji HM; Shi XC; Bi H; Zhai LQ; Han DW Brain Behav; 2020 Apr; 10(4):e01583. PubMed ID: 32146731 [TBL] [Abstract][Full Text] [Related]
17. Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma. Lin W; Qiu X; Sun P; Ye Y; Huang Q; Kong L; Lu JJ Mol Ther Oncolytics; 2021 Jun; 21():288-302. PubMed ID: 34141867 [TBL] [Abstract][Full Text] [Related]
18. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas. Paul Y; Mondal B; Patil V; Somasundaram K Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842 [TBL] [Abstract][Full Text] [Related]
20. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas. Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]